Two more attempts were made to get Glybera passed, both of which were rejected.
FORBES: Europe Takes The Lead Toward Approval Of First Gene Therapy Drug
2.
But getting to this stage has been a challenging journey for Glybera as gene therapy has struggled to get traction among drug regulators.
FORBES: Europe Takes The Lead Toward Approval Of First Gene Therapy Drug
3.
Last month, the European Union approved Glybera for treatment of a rare genetic disease, making it the first gene-therapy medicine approved in the Western world.
WSJ: The Future of Medicine Is Now: Medical Innovations